# Drug Utilisation of Mysimba/Contrave

> **NCT06089824** · — · COMPLETED · sponsor: **Currax Pharmaceuticals** · enrollment: 43324 (actual)

## Conditions studied

- Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06089824
- **Lead sponsor:** Currax Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 43324 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089824, "Drug Utilisation of Mysimba/Contrave". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06089824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*